From Sanger Sequencing to the Human Genome Project: The Evolution of DNA Sequencing Technology
In this inspiring interview, we speak to Dr. Radoje Drmanac, co-founder of Complete Genomics, about the past, present, and future…
New tool provides insight into the developmental history of certain immune cells
A new tool that can uncover the developmental history of certain immune cells is now freely available worldwide. The tool…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…
AI-designed T-cell vaccine extremely effective at preventing severe COVID-19 in mice
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to…